SCHEMBL785277

SCHEMBL785277

c1ccc(-c2cccc(-c3ccccc3)c2Oc2cccc3c2-c2nc-3nc3[nH]c(nc4nc(nc5[nH]c(n2)c2cccc(Oc6c(-c7ccccc7)cccc6-c6ccccc6)c52)-c2cccc(Oc5c(-c6ccccc6)cccc5-c5ccccc5)c2-4)c2cccc(Oc4c(-c5ccccc5)cccc4-c4ccccc4)c32)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.33
▸ TSHR P16473 3/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ MAPT P10636 2/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ CYP1A2 P05177 2/20 0.33
▸ CYP3A4 P08684 2/20 0.33
▸ CYP2C19 P33261 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ POLB P06746 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ MAPK1 P28482 2/20 0.32
▸ GAA P10253 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ MAP4K4 O95819 1/20 0.32
▸ CSF1R P07333 1/20 0.32
▸ FGFR1 P11362 1/20 0.32
▸ PDGFRA P16234 1/20 0.32
▸ LTK P29376 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL633608 0.87 BRD4 (0.34) LMNATSHRALDH1A1MAPTKDM4E
SCHEMBL14769816 0.86 CAMKK2 (0.38) KDM4EMAP4K4MAPK8MCL1MEN1
Hydrochloric Acid SCHEMBL3136757 0.85 BRD4 (0.33) LMNATSHRALDH1A1MAPTKDM4E
SCHEMBL9360821 0.81 BRD4 (0.33) LMNAMAPTPOLBMAPK1CDK1
SCHEMBL5972535 0.80 MEN1 (0.36) LMNATSHRALDH1A1MAPTKDM4E
SCHEMBL27279407 0.79 MEN1 (0.35) LMNATSHRALDH1A1MAPTKDM4E
SCHEMBL7131959 0.78 BRD4 (0.36) LMNATSHRALDH1A1MAPTKDM4E
SCHEMBL14610187 0.78 LMNA (0.39) LMNATSHRALDH1A1MAPTKDM4E
SCHEMBL12200946 0.77 PDE5A (0.42) ALDH1A1MAPTMAPK1GAATDP1
SCHEMBL9438281 0.76 MEN1 (0.34) MEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120068123-A1 USE OF PHTHALOCYANINE COMPOUNDS WITH ARYL OR HETARYL SUBSTITUENTS IN ORGANIC SOLAR CELLS BASF SE (DE) 2012-03-22 — — US disclosed
US-20120068123-A1 USE OF PHTHALOCYANINE COMPOUNDS WITH ARYL OR HETARYL SUBSTITUENTS IN ORGANIC SOLAR CELLS BASF SE (DE) 2012-03-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120068123-A1 USE OF PHTHALOCYANINE COMPOUNDS WITH ARYL OR HETARYL SUBSTITUENTS IN ORGANIC SOLAR CELLS RB1, NRAS, HLA-B LMNA 1253/4885TSHR 3595/4885ALDH1A1 761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback